Biotech Stocks to Watch during COVID-19 vaccine race

Dubai, United Arab Emirates, -Wednesday 29 April 2020 [ AETOS Wire ]

The corona situation is getting worse day by day in the world; lockdown continues in many countries across the globe, and the virus has infected more than 2 million people leaving around 120,000 people dead. Currently, a lot of companies are involved in the development of a coronavirus vaccine. The pharmaceutical companies continue the race to be the first to license a COVID-19 vaccine and some of them have already made great progress, while others are at the very beginning of the race. Every company is using different technology platforms to create experimental vaccines.

Here are the 6 important Biotech stocks that we think the investors should watch now. Gulf Brokers see, however, huge volatility in these stocks as investors will continue to speculate as to whether these companies will, as for the vaccine, come out on top.

Gilead Sciences Inc. (NASDAQ: GILD)

Johnson & Johnson, Inc. (NYSE: JNJ)

GlaxoSmithKline plc. (LON: GSK) and Sanofi (EPA: SAN)

Pfizer, Inc. (NYSE: PFE)

Moderna, Inc. (NASDAQ: MRNA)

Inovio Pharmaceuticals (NASDAQ: INO)

Medical companies worldwide are tirelessly working to develop vaccines and treatment for COVID-19. We expect a further upside strength in the biotech and pharmaceutical sectors during this crisis. But as we know, these experimental drugs are in the early stages and there is no guarantee that these drugs will achieve the FDA approval. The good news is that a number of biotech firms have already received the support of government funding.

Syam K.P.

Chief Analyst

Gulf Brokers

Trading is risky and your entire investment may be at risk. TC’s available at

Ziad El-Maadawi, +201227884844



Permalink :

Go Back


Blog Sear


There are currently no blog comments.